Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

<h4>Background</h4> <p>Renal transplant recipients (RTR) frequently develop complications relating to chronic immunosuppression. Identifying RTR who could safely reduce immunosuppression is therefore highly desirable. We hypothesized that “signatures” described in RTR who have sto...

Detaylı Bibliyografya
Asıl Yazarlar:	Bottomley, M, Chen, M, Fuggle, S, Harden, P, Wood, K
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Lippincott, Williams and Wilkins 2016

Benzer Materyaller

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
Yazar:: Ramon M. Rodriguez, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Update on the long-term complications of renal transplantation.
Yazar:: Bottomley, M, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
Yazar:: Bottomley, M, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
Yazar:: Mysore K. Phanish, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
Yazar:: Bittar, A, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
Yazar:: Bottomley, MJ, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Yazar:: Procter, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
Yazar:: I G Rekhtina, ve diğerleri
Baskı/Yayın Bilgisi: (2008-07-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
Yazar:: Matthew J. Bottomley, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
Yazar:: Sh. R. Galeev, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
Yazar:: Procter, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
Yazar:: Ratcliffe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
Yazar:: Alessandro C. Rosa, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
Yazar:: Alfonso J. Rodriguez-Morales, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
Yazar:: Bottomley, M
Baskı/Yayın Bilgisi: (2015)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
Yazar:: Katherine A. Barraclough, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
Yazar:: Lally, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
Yazar:: Rahbaninobar Mohammad, ve diğerleri
Baskı/Yayın Bilgisi: (2004-09-01)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
Yazar:: Noa Scott, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
Yazar:: Cvetković Tatjana, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
Yazar:: Muduma G, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
Yazar:: Iqbal A, ve diğerleri
Baskı/Yayın Bilgisi: (2000-01-01)

Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.
Yazar:: Jacek Pliszczynski, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
Yazar:: Brook, MO, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
Yazar:: Sofia Christakoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature
Yazar:: Joyita Bharati, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
Yazar:: Koen G. A. M. Hussaarts, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
Yazar:: Knight, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
Yazar:: Kentaro Ide, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients
Yazar:: Pengpeng Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection
Yazar:: Amitabh Jha, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
Yazar:: Susan Dutton, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
Yazar:: Ohe, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
Yazar:: Jade M Kozuch, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
Yazar:: Catherine Zilberg, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
Yazar:: Andreas Krisl, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
Yazar:: Dagmara Szypulska-Koziarska, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
Yazar:: V. Ram Peddi, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Predictors of cancer risk in the long-term solid-organ transplant recipient.
Yazar:: Sherston, SN, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
Yazar:: Jennifer Felicia Scheel, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)